COLUMBUS — The Ohio Department of Health has reportedly banned the use of hydroxychloroquine in treating COVID-19. The rule goes into effect Thursday.
Ohio Department of Health spokesperson Melanie Amato made the announcement, saying the drug touted by President Donald Trump is “not an effective treatment.”
According to WHIO, the rule “prohibits selling or dispensing hydroxychloroquine and chloroquine for the treatment or prevention of COVID-19.”
This comes after a group of Doctors held “America’s Frontline Doctors Summit” in Washington, D.C., in which the medical experts praised the use of hydroxychloroquine and some said there was no need for a mask mandate or economic shutdown.
The video, which was shared by President Trump on Twitter, was pulled by Twitter, YouTube/Google and Facebook. The tech giants labeled the news conference as spreading “false information.” As an interesting aside, my previous blog entry: https://lenbilen.com/2020/07/28/the-corona-virus-cure-early-treatment-with-hydroxychloroquine-zinc-zithromax-negative-studies-all-dealt-with-late-stage-hospitalized-patients/ can only be searched by bing, duckduckgo and yahoo, but not google. I wonder why.
For as long as as it lasts, here is a comment about the discontinued video:
In Ohio there is about 25 deaths a day, and about half of them would be eliminated if HCQ was endorsed as effective if administered as early as possible a. This means that between now and election at least 1200 lives are sacrificed, all in an effort to prolong the COVID hysteria and ensure a Democratic win in November. And this is for Ohio alone! Forty-four states have limitations on HCQ use to treat Covid-19 as an out patient.
Updated: The next day GOP Ohio Gov. Mike DeWine reportedly urged the state’s pharmacy board to withdraw a proposed ban of hydroxychloroquine and chloroquine for use as coronavirus treatments.
Under the proposed ban, pharmacies, clinics and other medical institutions would’ve been prohibited from dispensing or selling the drugs to treat COVID-19. But in an announcement Thursday, the pharmacy board pulled back the regulation change, stating it would reexamine the issue.